ARIEL is a clinical trial looking at whether extra tests on cancer samples can identify more patients with bowel/colon cancer who should be treated with drugs called anti-EGFR agents.
This website is intended to help:
- Patients and the public who want to know more about ARIEL – use the For Patients link above
- Healthcare professionals – use the For Researchers link above
/// image ///